A modified synthesis of iodoazidoaryl prazosin.

Article Details

Citation

Copy to clipboard

Andrus MB, Mettath SN, Song C

A modified synthesis of iodoazidoaryl prazosin.

J Org Chem. 2002 Nov 15;67(23):8284-6.

PubMed ID

12423172 [ View in PubMed

]

Abstract

The antihypertension agent iodoazidoaryl prazosin (IAAP) has been made using a convergent route involving addition of an acylated piperazine 7 to 2-chloroquinazoline 5. IAAP has been shown to function as a multidrug resistance (MDR) reversal agent and bind to P-glycoprotein, a transmembrane transport protein. A study is also reported involving palladium-catalyzed substitution with amine heterocycles. With N,N-bis(2,6-diisopropyl)dihydroimidazolium chloride (10) as the ligand (2 mol %) for palladium(II) acetate (2 mol %) in THF at room temperature, morpholine added to 5 in 81% yield.

DrugBank Data that Cites this Article

Drug Transporters

Drug	Transporter	Kind	Organism	Pharmacological Action	Actions
Prazosin	P-glycoprotein 1	Protein	Humans	Unknown	Substrate Inhibitor Modulator	Details